Women's Health Resources
Featured Centers
- Eating Out? Cut Calories, Heartburn
- 5 Good Ways to Save Money on Medicine
- 8 Ways to Treat Your Allergies
Gastroesophageal Reflux Disease (GERD) »
|
|
There have been no reports of significant overdose of KAPIDEX (dexlansoprazole delayed release capsules) . Multiple doses of KAPIDEX (dexlansoprazole delayed release capsules) 120 mg and a single dose of KAPIDEX (dexlansoprazole delayed release capsules) 300 mg did not result in death or other severe adverse events. Dexlansoprazole is not expected to be removed from the circulation by hemodialysis. If an overdose occurs, treatment should be symptomatic and supportive.
KAPIDEX (dexlansoprazole delayed release capsules) is contraindicated in patients with known hypersensitivity to any component of the formulation [see DESCRIPTION]. Hypersensitivity and anaphylaxis have been reported with KAPIDEX use [see ADVERSE REACTIONS].
Last reviewed on RxList: 4/14/2010
This monograph has been modified to include the generic and brand name in many instances.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.